Notification of Change in Auditor

RNS Number : 0215R

Mediclinic International PLC

04 March 2016

 

Mediclinic International plc (the "Company")
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

4 March 2016

NOTIFICATION OF CHANGE IN AUDITOR

Further to the announcement of 22 February 2016 regarding the change in the Company's auditor, the Company hereby advises that KPMG LLP, the Company's previous auditors, ceased to hold office on 19 February 2016 and, as required in terms of section 519(3) of the UK Companies Act 2006, have deposited a statement with the Company of the circumstances connected with them ceasing to hold office as auditors of the Company.

In accordance with the requirements of section 520(2) of the UK Companies Act 2006, a copy of the statement received from KPMG LLP has today been sent to all shareholders together with an explanatory letter from the Company's Chief Executive Officer, Danie Meintjes.

In compliance with UKLA Listing Rule 9.6.1 the Company announces that the following documents have been submitted electronically to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM:

·       letter from KPMG LLP including a statement of circumstances connected with ceasing to hold office as auditors; and

·       Chief Executive Officer's explanatory letter.

The documents will also be available shortly on the Investor Relations section of the Company's website at www.mediclinic.com.   

Registered address: 1^st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Limited

For further information, please contact:

Company Secretary

Victoria Dalby               [phone]

Capita Company Secretarial Services Limited

 

END

 

 

MSCSSEFWDFMSEDD